Skip to main content
logo
Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.460
+0.120 (3.59%)
At close: May 1, 2026, 4:00 PM EDT
3.470
+0.010 (0.29%)
After-hours: May 1, 2026, 7:12 PM EDT

Alvotech Revenue

In the year 2025, Alvotech had annual revenue of $588.90M with 19.70% growth. Alvotech had revenue of $168.90M in the quarter ending December 31, 2025, with 10.14% growth.

Revenue (ttm)
$588.90M
Revenue Growth
+19.70%
P/S Ratio
1.84
Revenue / Employee
$460,441
Employees
1,279
Market Cap
1.08B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025588.90M96.93M19.70%
Dec 31, 2024491.98M398.60M426.84%
Dec 31, 202393.38M8.37M9.84%
Dec 31, 202285.02M45.33M114.23%
Dec 31, 202139.68M-29.77M-42.86%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Evotec SE925.65M
Tilray Brands858.28M
Collegium Pharmaceutical780.57M
Pacira BioSciences734.86M
Amphastar Pharmaceuticals719.89M
Esperion Therapeutics403.14M
Ironwood Pharmaceuticals296.15M
Harrow272.30M
Revenue Rankings

ALVO News

More News